ContextVision AB (publ) (0L8Z) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Contextvision Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.010 -- 00:00:06.498 Welcome to Comtex Vision and thank you for joining our Q1 2025 webcast. 00:00:06.498 -- 00:00:10.323 Today with Richard Hallström, our CFO, and myself, Gerald. 00:00:10.323 -- 00:00:14.309 As usual, we'll give you an update on our business, we'll look into the financials and 00:00:14.309 -- 00:00:19.336 we'll close with a summary and outlook. Looking into the first quarter. 00:00:19.336 -- 00:00:24.562 The first clear highlight, which is also a very important milestone in the journey 00:00:24.562 -- 00:00:29.188 of the company, is the execution of a partnership agreement with the University of Washington 00:00:29.188 -- 00:00:30.970 in Seattle, 00:00:30.970 -- 00:00:36.196 United States. This is to support our journey in delivering 00:00:36.196 -- 00:00:41.543 and building digital organ-specific ultrasound-based biomarkers, 00:00:41.543 -- 00:00:45.307 a clear step forward in our journey towards data quality. 00:00:45.307 -- 00:00:50.475 In line with that partnership agreement and to enable clinical research, we have 00:00:50.475 -- 00:00:55.723 also executed investments into ultrasound equipment, which is going to be shipped 00:00:55.723 -- 00:01:00.831 in the second quarter to the University of Washington for clinical research. 00:01:00.831 -- 00:01:06.861 We have also seen ongoing fruitful collaboration with leading OEMs, 00:01:06.861 -- 00:01:11.429 expanding our footprint into the image processing chain. 00:01:11.429 -- 00:01:17.118 Financially, revenue came down to 26.3 million SEK, which 00:01:17.118 -- 00:01:22.707 is an adjusted EBITDA of 2.1 million SEK or 8.1%. 00:01:22.707 -- 00:01:25.392 Those investments 00:01:25.392 -- 00:01:30.640 in data quality are adjusted in those EBITDA figures. 00:01:30.640 -- 00:01:36.910 Ove...